Melanoma in children and adolescents
- PMID: 14642927
- DOI: 10.1016/j.ejca.2003.06.001
Melanoma in children and adolescents
Abstract
Childhood and adolescent melanoma is rare, accounting for only 1.3% for all cases of cancer in patients under the age of 20 years. However, in 15-19 year olds, melanoma accounts for up to 7% of all cancers. Review of reported cases in this age group reveals that predisposing 'paediatric' conditions such as a giant congenital melanocytic naevi or xeroderma pigmentosum are rarely present. Furthermore, inactivating germ-line mutations of the gene CDKN2A have only been reported in 1.5% of cases of early onset melanoma. Epidemiological studies suggest that interactions between solar exposure, development of naevi, pigmentary traits, and a family history of melanoma are the main determinants of melanoma development during the first 20 years of life. As yet, there are no available staging or treatment strategies for this group of patients so treatment recommendations are based on the adult experience. To improve our understanding of the natural history of melanoma and to identify the most appropriate therapies for young patients with this disease, practising physicians are encouraged to enroll their patients, especially those with advanced stage disease, in cooperative group trials which incorporate newer staging systems and promising therapies.
Similar articles
-
Malignant melanoma in xeroderma pigmentosum patients: report of five cases.Eur J Surg Oncol. 1997 Feb;23(1):43-7. doi: 10.1016/s0748-7983(97)80141-2. Eur J Surg Oncol. 1997. PMID: 9066746
-
[Melanoma in xeroderma pigmentosum: 12 cases].Ann Dermatol Venereol. 2001 Apr;128(4):503-6. Ann Dermatol Venereol. 2001. PMID: 11395647 French.
-
[Malignant melanoma in childhood and adolescence].Harefuah. 1996 Jun 16;130(12):843-50. Harefuah. 1996. PMID: 8885511 Review. Hebrew. No abstract available.
-
Malignant melanoma: a review.J Dermatol Surg Oncol. 1977 Jan-Feb;3(1):41-125. doi: 10.1111/j.1524-4725.1977.tb00254.x. J Dermatol Surg Oncol. 1977. PMID: 325046 Review. No abstract available.
-
Risk factors for childhood melanoma in Queensland, Australia.Int J Cancer. 1997 Jan 6;70(1):26-31. doi: 10.1002/(sici)1097-0215(19970106)70:1<26::aid-ijc4>3.0.co;2-8. Int J Cancer. 1997. PMID: 8985086
Cited by
-
Regional lymph node evaluation in pediatric conventional melanoma subtype: a single-center 10-year review.Pediatr Surg Int. 2024 Mar 5;40(1):68. doi: 10.1007/s00383-024-05646-8. Pediatr Surg Int. 2024. PMID: 38441654 Free PMC article.
-
Rapid disease progression on immune checkpoint inhibitors in young patients with stage IV melanoma.Front Med (Lausanne). 2023 Jan 23;10:1117816. doi: 10.3389/fmed.2023.1117816. eCollection 2023. Front Med (Lausanne). 2023. PMID: 36756176 Free PMC article.
-
International Society of Paediatric Surgical Oncology (IPSO) Surgical Practice Guidelines.Ecancermedicalscience. 2022 Feb 17;16:1356. doi: 10.3332/ecancer.2022.1356. eCollection 2022. Ecancermedicalscience. 2022. PMID: 35510137 Free PMC article.
-
Immunotherapy in Adolescents and Young Adults: What Remains in Cancer Survivors?Front Oncol. 2021 Sep 23;11:736123. doi: 10.3389/fonc.2021.736123. eCollection 2021. Front Oncol. 2021. PMID: 34631569 Free PMC article. Review.
-
Malignant Melanoma in Children and Adolescents Treated in Pediatric Oncology Centers: An Australian and New Zealand Children's Oncology Group (ANZCHOG) Study.Front Oncol. 2021 Apr 29;11:660172. doi: 10.3389/fonc.2021.660172. eCollection 2021. Front Oncol. 2021. PMID: 33996584 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous